Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Neurogastroenterology and Motility|August 31, 2007
Assessment of 24-h oesophageal pH monitoring should be divided to awake and asleep rather than upright and supine time periodsR Dickman, M Shapiro, I B Malagon, et al.Alimentary Pharmacology & Therapeutics|March 8, 2003
Non-erosive reflux disease (NERD)--acid reflux and symptom patternsS D Martinez, I B Malagon, H S Garewal, et al.Alimentary Pharmacology & Therapeutics|June 9, 2007
Comparisons of the distribution of oesophageal acid exposure throughout the sleep period among the different gastro-oesophageal reflux disease groupsR Dickman, S Parthasarathy, I B Malagon, et al.Alimentary Pharmacology & Therapeutics|December 21, 2000
Omeprazole 40 mg once a day is equally effective as lansoprazole 30 mg twice a day in symptom control of patients with gastro-oesophageal reflux disease (GERD) who are resistant to conventional-dose lansoprazole therapy-a prospective, randomized, multi-centre studyR Fass, U Murthy, C W Hayden, et al.Alimentary Pharmacology & Therapeutics|May 3, 2000
Failure of oesophageal acid control in candidates for Barrett's oesophagus reversal on a very high dose of proton pump inhibitorR Fass, R E Sampliner, I B Malagon, et al.Alimentary Pharmacology & Therapeutics|February 1, 2005
Feasibility and tolerability of transnasal/per-oral placement of the wireless pH capsule vs. traditional 24-h oesophageal pH monitoring--a randomized trialW-M Wong, J Bautista, R Dekel, et al.Pageof 1